How to use Technologies searched

A search for a company looking for a cancer, preclinical stage, synthetic opportunity would use the selection "Biomedicine, Diagnostics" in 'Sector', 'Cancerous, neoplasmatic' in 'Disease Category', 'Drugs, Small Molecule' in 'Technology' and 'Preclinical' in 'Development Stage'.

Selection of 'Enabling Technology, Platform technology' in 'Sector' will identify all kinds of searches for technologies that can be used in more areas of life sciences than pharmaceuticals only.

Each search profile gives the name or a short description of the company behind the search, and a link allowing to contact your potential licensee.

Registered users can create non-public notifications profiles which will inform them about new Technologies Searched entries fitting their expertise as specified. In addition these profiles allow them to filter the available information more comfortably.

Name

The Medicines Company is seeking late stage partnerships in Acute Care

Organization name

The Medicines Company business development

Profile

The Medicines Company meets the demands of the world's most advanced medical practitioners by developing products that improve acute hospital care. They acquire, develop and commercialize pharmaceutical products in late stages of their development. They focus their commercial and product development resources primarily on the U.S. hospital market.

They intend to continue building their acute care franchise of hospital products by selectively acquiring and developing late-stage product candidates or products approved for marketing.

They seek product licensing deals with larger pharmaceutical companies in the process of refining their own product portfolios and from smaller companies seeking specialist development or commercial collaborations.

In evaluating product acquisition candidates, they will continue to seek products that have the potential to alleviate the growing pressures on U.S. hospitals to treat patients more efficiently.

In general, they look for:

  1. an anticipated time from acquisition to commercialization of four years or less
  2. existing clinical data which provides reasonable evidence of safety and efficacy
  3. the potential to reduce a patient's hospital stay. In addition, we may acquire approved products that can be marketed in hospitals by our commercial organization.

To view the contact information, attachments and url of this profile you have to login into your account or register a new account: Login Register

Your feedback

Please click here to log in to view the complete profile.

 
 

latest entries